Michael Doubek
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 82
- Myeloproliferative Neoplasms: Diagnosis and Treatment 10
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments 26
- Acute Myeloid Leukemia Research 18
- Hematopoietic Stem Cell Transplantation 12
-
- Lymphoma Diagnosis and Treatment 53
- Immunology top 5%
- Immunodeficiency and Autoimmune Disorders 28
- Oncology top 5%
-
- Acute Lymphoblastic Leukemia research 26
In The Last Decade
Michael Doubek
155 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Genetics 984
- Hematology 702
- Pathology and Forensic Medicine 676
- Immunology 510
- Oncology 519
Countries citing papers authored by Michael Doubek
This map shows the geographic impact of Michael Doubek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Doubek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Doubek more than expected).
Fields of papers citing papers by Michael Doubek
This network shows the impact of papers produced by Michael Doubek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Doubek. The network helps show where Michael Doubek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Doubek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 0 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 10 | |
| 13 | 2021 | 24 | |
| 14 | 2021 | 10 | |
| 15 | 2017 | 66 | |
| 16 | 2015 | 52 | |
| 17 | 2013 | 82 | |
| 18 | New prognostic markers of chronic lymphocytic leukemia in theeveryday hematological practice. A multicenter analysis. | 2009 | 0 |
| 19 | 2004 | 3 | |
| 20 | Imunomagnetická separace myelomových buněk. | 2001 | 1 |
About Michael Doubek
Michael Doubek is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 169 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (82 papers), Lymphoma Diagnosis and Treatment (53 papers), Immunodeficiency and Autoimmune Disorders (28 papers), Chronic Myeloid Leukemia Treatments (26 papers), Acute Lymphoblastic Leukemia research (26 papers), Acute Myeloid Leukemia Research (18 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers). The work is most often cited by research in Genetics (984 citations), Hematology (702 citations) and Pathology and Forensic Medicine (676 citations). Michael Doubek has collaborated with scholars based in Czechia, Germany and France. Frequent co-authors include Jiřı́ Mayer, Yvona Brychtová, Šárka Pospı́šilová, Martin Trbušek, Boris Tichý, Karla Plevová, Jitka Malčíková, Marek Mráz, Šárka Pavlová and Jana Kotašková. Their work appears in journals such as Blood, Leukemia, Leukemia Research, European Journal Of Haematology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.